| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4127061 | Otolaryngology - Head and Neck Surgery | 2007 | 7 Pages |
Abstract
Recombinant VSV-F confers a modest survival benefit for HNSCC in this orthotopic murine model. This oncolytic virus holds promise as a novel cancer treatment for recurrent HNSCC.
Related Topics
Health Sciences
Medicine and Dentistry
Otorhinolaryngology and Facial Plastic Surgery
Authors
Edward J. MD, Jaime I. MD, Bryan MS, Georges MD, Oliver MD, Eric M. MD, Savio L.C. PhD,